{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:08Z","timestamp":1740107708835,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C1324"],"award-info":[{"award-number":["HI14C1324"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"crossref","award":["6-2019-0184"],"award-info":[{"award-number":["6-2019-0184"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10067-021-05701-y","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T09:02:34Z","timestamp":1616490154000},"page":"3703-3710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody\u2013associated vasculitis"],"prefix":"10.1007","volume":"40","author":[{"given":"Taejun","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Yoon","family":"Pyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy Eunju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason Jungsik","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8038-3341","authenticated-orcid":false,"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"issue":"1","key":"5701_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311. https:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"issue":"2","key":"5701_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66(2):222\u2013227. https:\/\/doi.org\/10.1136\/ard.2006.054593","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5701_CR3","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, Jones R, Lanyon P, Muir A, Scott D, Young L, Luqmani RA (2009) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68(12):1827\u20131832. https:\/\/doi.org\/10.1136\/ard.2008.101279","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5701_CR4","doi-asserted-by":"publisher","first-page":"e23022","DOI":"10.1002\/jcla.23022","volume":"34","author":"MK Kim","year":"2020","unstructured":"Kim MK, Choi H, Kim JY, Song JJ, Park YB, Lee SW (2020) Multivariable index for assessing the activity and predicting all-cause mortality in antineutrophil cytoplasmic antibody-associated vasculitis. J Clin Lab Anal 34(1):e23022. https:\/\/doi.org\/10.1002\/jcla.23022","journal-title":"J Clin Lab Anal"},{"issue":"10","key":"5701_CR5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00296-018-4125-y","volume":"38","author":"HJ Park","year":"2018","unstructured":"Park HJ, Jung SM, Song JJ, Park YB, Lee SW (2018) Platelet to lymphocyte ratio is associated with the current activity of ANCA-associated vasculitis at diagnosis: a retrospective monocentric study. Rheumatol Int 38(10):1865\u20131871. https:\/\/doi.org\/10.1007\/s00296-018-4125-y","journal-title":"Rheumatol Int"},{"issue":"1","key":"5701_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12882-018-0992-4","volume":"19","author":"SS Ahn","year":"2018","unstructured":"Ahn SS, Jung SM, Song JJ, Park YB, Lee SW (2018) Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: a retrospective study. BMC Nephrol 19(1):187. https:\/\/doi.org\/10.1186\/s12882-018-0992-4","journal-title":"BMC Nephrol"},{"issue":"1","key":"5701_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1186\/s12885-019-6321-x","volume":"19","author":"J Shi","year":"2019","unstructured":"Shi J, Huo R, Li N, Li H, Zhai T, Li H, Shen B, Ye J, Fu R, Di W (2019) CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress. BMC Cancer 19(1):1140. https:\/\/doi.org\/10.1186\/s12885-019-6321-x","journal-title":"BMC Cancer"},{"issue":"11","key":"5701_CR8","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1038\/jid.2015.231","volume":"135","author":"Y Sun","year":"2015","unstructured":"Sun Y, Zhang J, Zhou Z, Wu P, Huo R, Wang B, Shen Z, Li H, Zhai T, Shen B, Chen X, Li N (2015) CCN1, a pro-inflammatory factor, aggravates psoriasis skin lesions by promoting keratinocyte activation. J Invest Dermatol 135(11):2666\u20132675. https:\/\/doi.org\/10.1038\/jid.2015.231","journal-title":"J Invest Dermatol"},{"issue":"11","key":"5701_CR9","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.4049\/jimmunol.1103201","volume":"188","author":"J Lin","year":"2012","unstructured":"Lin J, Zhou Z, Huo R, Xiao L, Ouyang G, Wang L, Sun Y, Shen B, Li D, Li N (2012) Cyr61 induces IL-6 production by fibroblast-like synoviocytes promoting Th17 differentiation in rheumatoid arthritis. J Immunol 188(11):5776\u20135784. https:\/\/doi.org\/10.4049\/jimmunol.1103201","journal-title":"J Immunol"},{"key":"5701_CR10","doi-asserted-by":"publisher","first-page":"11888","DOI":"10.1038\/srep11888","volume":"5","author":"EC O\u2019Brien","year":"2015","unstructured":"O\u2019Brien EC, Abdulahad WH, Rutgers A, Huitema MG, O\u2019Reilly VP, Coughlan AM, Harrington M, Heeringa P, Little MA, Hickey FB (2015) Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1\u03b2 secretion in response to anti-MPO antibodies. Sci Rep 5:11888. https:\/\/doi.org\/10.1038\/srep11888","journal-title":"Sci Rep"},{"issue":"1","key":"5701_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semarthrit.2015.02.002","volume":"45","author":"A Berti","year":"2015","unstructured":"Berti A, Cavalli G, Campochiaro C, Guglielmi B, Baldissera E, Cappio S, Sabbadini MG, Doglioni C, Dagna L (2015) Interleukin-6 in ANCA-associated vasculitis: rationale for successful treatment with tocilizumab. Semin Arthritis Rheum 45(1):48\u201354. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.02.002","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"5701_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"JC Jennette","year":"2014","unstructured":"Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10(8):463\u2013473. https:\/\/doi.org\/10.1038\/nrrheum.2014.103","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"5701_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1620\/tjem.203.189","volume":"203","author":"CW Han","year":"2004","unstructured":"Han CW, Lee EJ, Iwaya T, Kataoka H, Kohzuki M (2004) Development of the Korean version of Short-Form 36-Item Health Survey: health related QOL of healthy elderly people and elderly patients in Korea. Tohoku J Exp Med 203(3):189\u2013194. https:\/\/doi.org\/10.1620\/tjem.203.189","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"5701_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, French Vasculitis Study Group (FVSG) (2011) The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90(1):19\u201327. https:\/\/doi.org\/10.1097\/MD.0b013e318205a4c6","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"5701_CR15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s11926-012-0291-1","volume":"14","author":"K Bhamra","year":"2012","unstructured":"Bhamra K, Luqmani R (2012) Damage assessment in ANCA-associated vasculitis. Curr Rheumatol Rep 14(6):494\u2013500. https:\/\/doi.org\/10.1007\/s11926-012-0291-1","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"5701_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.ajpath.2013.06.016","volume":"183","author":"F Fang","year":"2013","unstructured":"Fang F, Shangguan AJ, Kelly K, Wei J, Gruner K, Ye B, Wang W, Bhattacharyya S, Hinchcliff ME, Tourtellotte WG, Varga J (2013) Early growth response 3 (Egr-3) is induced by transforming growth factor-\u03b2 and regulates fibrogenic responses. Am J Pathol 183(4):1197\u20131208. https:\/\/doi.org\/10.1016\/j.ajpath.2013.06.016","journal-title":"Am J Pathol"},{"issue":"Pt 14","key":"5701_CR17","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1242\/jcs.02445","volume":"118","author":"GD Wieland","year":"2005","unstructured":"Wieland GD, Nehmann N, M\u00fcller D, Eibel H, Siebenlist U, S\u00fchnel J, Zipfel PF, Skerka C (2005) Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-kappaB p50 and p65. J Cell Sci 118(Pt 14):3203\u20133212. https:\/\/doi.org\/10.1242\/jcs.02445","journal-title":"J Cell Sci"},{"key":"5701_CR18","doi-asserted-by":"publisher","first-page":"43310","DOI":"10.1038\/srep43310","volume":"7","author":"Y Sun","year":"2017","unstructured":"Sun Y, Zhang J, Zhai T, Li H, Li H, Huo R, Shen B, Wang B, Chen X, Li N, Teng J (2017) CCN1 promotes IL-1\u03b2 production in keratinocytes by activating p38 MAPK signaling in psoriasis. Sci Rep 7:43310. https:\/\/doi.org\/10.1038\/srep43310","journal-title":"Sci Rep"},{"issue":"6","key":"5701_CR19","doi-asserted-by":"publisher","first-page":"R187","DOI":"10.1186\/ar4377","volume":"15","author":"X Zhu","year":"2013","unstructured":"Zhu X, Xiao L, Huo R, Zhang J, Lin J, Xie J, Sun S, He Y, Sun Y, Zhou Z, Shen B, Li N (2013) Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 15(6):R187. https:\/\/doi.org\/10.1186\/ar4377","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"5701_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5414\/CN108902","volume":"86","author":"M Tashiro","year":"2016","unstructured":"Tashiro M, Sasatomi Y, Watanabe R, Watanabe M, Miyake K, Abe Y, Yasuno T, Ito K, Ueki N, Hamauchi A, Noda R, Hisano S, Nakashima H (2016) IL-1\u03b2 promotes tubulointerstitial injury in MPO-ANCA-associated glomerulonephritis. Clin Nephrol 86(10):190\u2013199. https:\/\/doi.org\/10.5414\/CN108902","journal-title":"Clin Nephrol"},{"issue":"11","key":"5701_CR21","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.autrev.2017.09.012","volume":"16","author":"KH Lee","year":"2017","unstructured":"Lee KH, Kronbichler A, Park DD, Park Y, Moon H, Kim H, Choi JH, Choi Y, Shim S, Lyu IS, Yun BH, Han Y, Lee D, Lee SY, Yoo BH, Lee KH, Kim TL, Kim H, Shim JS, Nam W, So H, Choi S, Lee S, Shin JI (2017) Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review. Autoimmun Rev 16(11):1160\u20131173. https:\/\/doi.org\/10.1016\/j.autrev.2017.09.012","journal-title":"Autoimmun Rev"},{"issue":"19","key":"5701_CR22","doi-asserted-by":"publisher","first-page":"e834","DOI":"10.1097\/MD.0000000000000834","volume":"94","author":"J Lin","year":"2015","unstructured":"Lin J, Li N, Chen H, Liu C, Yang B, Ou Q (2015) Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus. Medicine (Baltimore) 94(19):e834. https:\/\/doi.org\/10.1097\/MD.0000000000000834","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"5701_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13075-019-1906-y","volume":"21","author":"Y Fan","year":"2019","unstructured":"Fan Y, Yang X, Zhao J, Sun X, Xie W, Huang Y, Li G, Hao Y, Zhang Z (2019) Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis. Arthritis Res Ther 21(1):123. https:\/\/doi.org\/10.1186\/s13075-019-1906-y","journal-title":"Arthritis Res Ther"},{"key":"5701_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fmed.2019.00266","volume":"6","author":"Y Su","year":"2019","unstructured":"Su Y, Wang Z, Ye J, Feng T, Wang F, Chi H, Zhou Z, Hu Q, Liu H, Cheng X, Shi H, Teng J, Yang C, Sun Y (2019) Cysteine-rich angiogenic inducer 61 serves as a potential serum biomarker for the remission of adult-onset still\u2019s disease. Front Med (Lausanne) 6:266. https:\/\/doi.org\/10.3389\/fmed.2019.00266","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"5701_CR25","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/mi.2015.19","volume":"8","author":"JS Choi","year":"2015","unstructured":"Choi JS, Kim KH, Lau LF (2015) The matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6. Mucosal Immunol 8(6):1285\u20131296. https:\/\/doi.org\/10.1038\/mi.2015.19","journal-title":"Mucosal Immunol"},{"issue":"6","key":"5701_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","volume":"16","author":"EH Choy","year":"2020","unstructured":"Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T (2020) Translating IL-6 biology into effective treatments. Nat Rev Rheumatol 16(6):335\u2013345. https:\/\/doi.org\/10.1038\/s41584-020-0419-z","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"5701_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1191\/0961203304lu1023oa","volume":"13","author":"E Tackey","year":"2004","unstructured":"Tackey E, Lipsky PE, Illei GG (2004) Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus 13(5):339\u2013343. https:\/\/doi.org\/10.1191\/0961203304lu1023oa","journal-title":"Lupus"},{"issue":"4 Suppl 92","key":"5701_CR28","first-page":"S11","volume":"33","author":"CG Kallenberg","year":"2015","unstructured":"Kallenberg CG (2015) Pathogenesis and treatment of ANCA-associated vasculitides. Clin Exp Rheumatol 33(4 Suppl 92):S11\u2013S14","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05701-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05701-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05701-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T09:13:33Z","timestamp":1628673213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05701-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5701"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05701-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"19 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Severance Hospital (4-2016-0901) and written informed consents were obtained from the patients at the time of blood sampling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}